These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29346420)

  • 21. Regional differences in infection and structural lung disease in infants and young children with cystic fibrosis.
    Carzino R; Frayman KB; King L; Vidmar S; Ranganathan S;
    J Cyst Fibros; 2020 Nov; 19(6):917-922. PubMed ID: 31706731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis.
    Gutierrez JP; Grimwood K; Armstrong DS; Carlin JB; Carzino R; Olinsky A; Robertson CF; Phelan PD
    Eur Respir J; 2001 Feb; 17(2):281-6. PubMed ID: 11334132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright CE; Smyth AR
    Cochrane Database Syst Rev; 2024 May; 5(5):CD009530. PubMed ID: 38700027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Culture-Independent Analysis of Pediatric Bronchoalveolar Lavage Specimens.
    Zachariah P; Ryan C; Nadimpalli S; Coscia G; Kolb M; Smith H; Foca M; Saiman L; Planet PJ
    Ann Am Thorac Soc; 2018 Sep; 15(9):1047-1056. PubMed ID: 29877714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical significance of oropharyngeal cultures in young children with cystic fibrosis.
    Breuer O; Caudri D; Akesson L; Ranganathan S; Stick SM; Schultz A;
    Eur Respir J; 2018 May; 51(5):. PubMed ID: 29678944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of bronchoscopy and bronchoalveolar lavage findings in three types of suppurative lung disease.
    de Vries JJV; Chang AB; Marchant JM
    Pediatr Pulmonol; 2018 Apr; 53(4):467-474. PubMed ID: 29405664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.
    Wainwright CE; Vidmar S; Armstrong DS; Byrnes CA; Carlin JB; Cheney J; Cooper PJ; Grimwood K; Moodie M; Robertson CF; Tiddens HA;
    JAMA; 2011 Jul; 306(2):163-71. PubMed ID: 21750293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright C; Smyth AR
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease surveillance using bronchoalveolar lavage.
    Brennan S; Gangell C; Wainwright C; Sly PD
    Paediatr Respir Rev; 2008 Sep; 9(3):151-9. PubMed ID: 18694706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study.
    Valenzi E; Yang H; Sembrat JC; Yang L; Winters S; Nettles R; Kass DJ; Qin S; Wang X; Myerburg MM; Methé B; Fitch A; Alder JK; Benos PV; McVerry BJ; Rojas M; Morris A; Kitsios GD
    Thorax; 2021 Mar; 76(3):239-247. PubMed ID: 33268457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright C; Smyth AR
    Cochrane Database Syst Rev; 2016 Jan; (1):CD009530. PubMed ID: 26797965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT.
    Mott LS; Park J; Murray CP; Gangell CL; de Klerk NH; Robinson PJ; Robertson CF; Ranganathan SC; Sly PD; Stick SM;
    Thorax; 2012 Jun; 67(6):509-16. PubMed ID: 22201161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The longitudinal microbial and metabolic landscape of infant cystic fibrosis: the gut-lung axis.
    Frayman KB; Macowan M; Caparros-Martin J; Ranganathan SC; Marsland BJ;
    Eur Respir J; 2024 May; 63(5):. PubMed ID: 38485151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis.
    Dakin CJ; Numa AH; Wang H; Morton JR; Vertzyas CC; Henry RL
    Am J Respir Crit Care Med; 2002 Apr; 165(7):904-10. PubMed ID: 11934712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower airway inflammation in infants and young children with cystic fibrosis.
    Armstrong DS; Grimwood K; Carlin JB; Carzino R; Gutièrrez JP; Hull J; Olinsky A; Phelan EM; Robertson CF; Phelan PD
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1197-204. PubMed ID: 9351622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis.
    Laguna TA; Wagner BD; Williams CB; Stevens MJ; Robertson CE; Welchlin CW; Moen CE; Zemanick ET; Harris JK
    PLoS One; 2016; 11(12):e0167649. PubMed ID: 27930727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung function and microbiota diversity in cystic fibrosis.
    Cuthbertson L; Walker AW; Oliver AE; Rogers GB; Rivett DW; Hampton TH; Ashare A; Elborn JS; De Soyza A; Carroll MP; Hoffman LR; Lanyon C; Moskowitz SM; O'Toole GA; Parkhill J; Planet PJ; Teneback CC; Tunney MM; Zuckerman JB; Bruce KD; van der Gast CJ
    Microbiome; 2020 Apr; 8(1):45. PubMed ID: 32238195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung clearance index-triggered intervention in children with cystic fibrosis - A randomised pilot study.
    Voldby C; Green K; Kongstad T; Ring AM; Sandvik RM; Skov M; Buchvald F; Pressler T; Nielsen KG
    J Cyst Fibros; 2020 Nov; 19(6):934-941. PubMed ID: 32576447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal lavage microbiome, but not nasal swab microbiome, correlates with sinonasal inflammation in children with cystic fibrosis.
    Chung J; Boutin S; Frey DL; Joachim C; Mall MA; Sommerburg O
    J Cyst Fibros; 2024 Mar; 23(2):226-233. PubMed ID: 38199892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
    Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
    PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.